Kowalsky Matthew Paul 4
4 · PROTEON THERAPEUTICS INC · Filed Jan 3, 2019
Insider Transaction Report
Form 4
Kowalsky Matthew Paul
VP, Legal and Secretary
Transactions
- Award
Common Stock
2018-12-31$1.93/sh+2,448$4,725→ 29,479 total
Footnotes (1)
- [F1]The shares were acquired under the Issuer's 2014 Employee Stock Purchase Plan for the plan period of July 1, 2018 through December 31, 2018 in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).